Needham & Company LLC Reaffirms Buy Rating for Mereo BioPharma Group (NASDAQ:MREO)

Needham & Company LLC restated their buy rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Get Rating) in a report released on Friday, Benzinga reports. Needham & Company LLC currently has a $5.00 price target on the stock. Mereo BioPharma Group Stock Performance Shares of MREO opened at $1.00 on Friday. Mereo BioPharma Group […]

Related Keywords

United Kingdom , ,Needham Company ,Millennium Management ,Capital Management ,News Ratings For Mereo Biopharma Group Daily ,Mereo Biopharma Group Company Profile ,Mereo Biopharma Group Stock Performance ,Mereo Biopharma Group ,Tejara Capital Ltd ,Toroso Investments ,Get Rating ,Street Group ,Capital Ltd ,Biopharma Group ,Mereo Biopharma Group Daily ,Nasdaq Mreo ,Mreo ,Medical ,Reiterated Rating ,Needham Amp Company Llc ,